Detalhe da pesquisa
1.
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE].
Harefuah
; 163(4): 236-243, 2024 Apr.
Artigo
em Hebraico
| MEDLINE | ID: mdl-38616634
2.
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Eur J Haematol
; 111(1): 63-71, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964939
3.
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies.
Eur J Nucl Med Mol Imaging
; 49(3): 953-962, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480603
4.
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.
Ann Hematol
; 101(8): 1769-1776, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731278
5.
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells.
Eur J Haematol
; 108(1): 52-60, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564876
6.
Advances in chimeric antigen receptor T cells.
Curr Opin Hematol
; 27(6): 368-377, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925186
7.
Lymphoma pseudoprogression observed on [18F]FDG PET-CT scan 15 days after CAR-T infusion.
Eur J Nucl Med Mol Imaging
; 49(7): 2447-2449, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35146579
8.
Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.
J Pathol
; 239(3): 262-73, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037906
9.
Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Cochrane Database Syst Rev
; 6: CD003914, 2017 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577308
10.
Should autotransplantation in acute myeloid leukemia in first complete remission be revisited?
Curr Opin Hematol
; 23(2): 88-94, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825697
11.
Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy.
Biol Blood Marrow Transplant
; 22(6): 975-981, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26740372
12.
Published abstracts at international meetings often over- or underestimate the initial response rate.
Blood
; 129(16): 2326-2328, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264800
13.
Primary Marginal Zone Lymphoma of the Lung and Organizing Pneumonia: A Diagnostic Challenge.
Isr Med Assoc J
; 20(3): 197-198, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29527863
14.
Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial.
Transplant Cell Ther
; 29(11): 708.e1-708.e8, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591446
15.
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort Study.
Transplant Cell Ther
; 28(5): 278.e1-278.e4, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182795
16.
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.
Transplant Cell Ther
; 27(9): 788-794, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214738
17.
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation.
Leuk Lymphoma
; 60(10): 2449-2456, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943060
18.
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy.
Mol Cancer Res
; 17(11): 2331-2340, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409628
19.
Novel Approaches to Acute Myeloid Leukemia Immunotherapy.
Clin Cancer Res
; 24(22): 5502-5515, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903894
20.
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.
Cancer Res
; 78(5): 1253-1265, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301792